Truist Financial Corp Natera, Inc. Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Natera, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 48,183 shares of NTRA stock, worth $8.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

48,183

Previous 40,697 18.39%

Holding current value

$8.12 Million

Previous $4.41 Million 38.96%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$97.75 - $129.67 $731,756 - $970,709	7,486 Added 18.39%	48,183 $6.12 Million
Q2 2024 Aug 20, 2024	SELL	$85.28 - $112.6 $265,647 - $350,749	-3,115 Reduced 7.11%	40,697 $4.41 Million
Q1 2024 May 10, 2024	BUY	$59.21 - $92.9 $393,509 - $617,413	6,646 Added 17.88%	43,812 $4.01 Million
Q4 2023 Feb 02, 2024	SELL	$37.55 - $62.64 $324,582 - $541,460	-8,644 Reduced 18.87%	37,166 $2.33 Million
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $289,738 - $417,383	6,676 Added 17.06%	45,810 $2.03 Million
Q2 2023 Aug 01, 2023	BUY	$47.08 - $55.16 $226,313 - $265,154	4,807 Added 14.0%	39,134 $1.9 Million
Q1 2023 May 05, 2023	SELL	$36.57 - $58.29 $497,169 - $792,452	-13,595 Reduced 28.37%	34,327 $1.91 Million
Q4 2022 Feb 17, 2023	BUY	$34.17 - $47.91 $252,652 - $354,246	7,394 Added 18.24%	47,922 $1.93 Million
Q3 2022 Oct 26, 2022	BUY	$36.93 - $56.68 $357,851 - $549,229	9,690 Added 31.42%	40,528 $1.78 Million
Q2 2022 Jul 22, 2022	SELL	$28.13 - $44.54 $305,491 - $483,704	-10,860 Reduced 26.04%	30,838 $1.09 Million
Q1 2022 Apr 22, 2022	SELL	$30.32 - $91.33 $1.08 Million - $3.26 Million	-35,727 Reduced 46.14%	41,698 $1.7 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $528,515 - $729,113	-6,127 Reduced 7.33%	77,425 $7.23 Million
Q3 2021 Nov 05, 2021	BUY	$100.17 - $126.36 $1.04 Million - $1.31 Million	10,376 Added 14.18%	83,552 $9.31 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $699,242 - $972,844	8,126 Added 12.49%	73,176 $8.31 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $1.72 Million - $2.34 Million	18,842 Added 40.78%	65,050 $6.61 Million
Q4 2020 Nov 19, 2021	SELL	$66.66 - $111.74 $366,563 - $614,458	-5,499 Reduced 10.63%	46,208 $4.6 Million
Q4 2020 Feb 18, 2021	BUY	$66.66 - $111.74 $1.08 Million - $1.81 Million	16,188 Added 45.58%	51,707 $5.15 Million
Q3 2020 Nov 13, 2020	BUY	$45.89 - $72.67 $717,077 - $1.14 Million	15,626 Added 78.55%	35,519 $2.57 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $197,041 - $372,703	7,475 Added 60.19%	19,893 $993,000
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $30,291 - $70,458	1,754 Added 16.45%	12,418 $370,000
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $342,314 - $430,825	10,664 New	10,664 $359,000

Others Institutions Holding NTRA

# of Institutions

528

Shares Held

119M

Call Options Held

308K

Put Options Held

191K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Natera, Inc. Transaction History